David Devos

David Devos

Professor in Medical Pharmacology

Professor David Devos obtained his degree in Neurology and Neuroscience from the University of Lille, France. Between 2002 and 2010, he worked as a hospital physician in the Department of Neurology, at the University Hospital of Lille, where he is now a Professor in Medical Pharmacology. He is fellow of the European Academy of Neurology and member of the committee of the Movement Disorders Society European Section of Education. His main research interests are preclinical and clinical studies of disease-modifying strategies in neurodegenerative disease and particularly Amyotrophic lateral sclerosis and Parkinson’s disease, for which he received several prices including the European Pharmacology Scientific Award EACPT, I-LAB and DeepTech prizes. He has authored more than 180 publications, 5 patents and 2 industrial transfers and a total career competitive research funding >11M€. He participated in 30 studies including 14 multicenter trials. He coordinated 14 studies (of which 10 are currently in progress), including the large European clinical trial FAIRPARK-2 funded by European Commission (H2020) and FAIR-ALS-II “Conservative Iron Chelation by Deferiprone as a Disease-modifying Strategy for Amyotrophic Lateral Sclerosis using a Multicentre, Parallel-group, Placebo-controlled, Randomized Clinical Trial on 240 patients. (Protocol ID: 2017-003763-35; ClinicalTrials.gov: NCT03293069)

Connect